The Hague
,
Netherlands
21 - 23 September 2023
The congress symposium is no longer available
The European Society for Paediatric Endocrinology (ESPE 2023)
Presentation materials
Thursday, 21 September 2023
POSTER
Pre-treatment blood transcriptome predicts growth response to somapacitan treatment in children born small for gestational age
Terence Garner1; Peter Clayton1,2; Michael Højby Rasmussen3; Philip Murray1,2; Adam Stevens1
Friday, 22 September 2023
POSTER
Clinical predictors of good/poor response to growth hormone treatment (GHT) in children with idiopathic short stature (ISS)
Andrew Dauber1; Moshe Phillip2,3; Jean-Marc Ferran4; Nicky Kelepouris5; Navid Nedjatian6; Anne Helene Olsen7; Alexander Jorge8
POSTER
Long-term effectiveness and safety of growth hormone therapy in Japanese children with short stature due to Noonan syndrome (NS): real-world data
Koji Muroya1; Masanobu Kawai2; Hiroyuki Yamagishi3; Takaaki Endo4; Alberto Pietropoli5; Reiko Horikawa6
POSTER
Persistence to growth hormone treatment and clinical characteristics of paediatric patients with growth hormone deficiency: a retrospective database study
Jun Mori1; Yukihito Sato2; Sumito Dateki3
POSTER
Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency: insights from an advisory board
Craig Alter1; Margaret Boguszewski2; David Clemmons3; Georgiana A. Dobri4; Mitchell E. Geffner5; Nicky Kelepouris6; Bradley S. Miller7; Rich Oh6; Heidi Shea8; Kevin C.J. Yuen9
Saturday, 23 September 2023
ORAL PRESENTATION
GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4
Bradley S. Miller1; Joanne C. Blair2; Michael Højby Rasmussen3; Aristides Maniatis4; Jun Mori5; Volker Böttcher6; Ho-Seong Kim7; Rikke Beck Bang8; Michel Polak9; Reiko Horikawa10
ORAL PRESENTATION
Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial
Arslanian S1; Goldman B2; Gies I3; Harder-Lauridsen NM4; Karlsson T4; Kelly AS5; Wabitsch M6; Weghuber D7
ORAL PRESENTATION
Effective GH replacement with once-weekly somapacitan in Japanese children with GH deficiency: 2-year results from REAL4
Yasuhisa Ohata1; Jun Mori2; Yasuko Fujisawa3; Yukihito Sato4; Sebastian Röhrich5; Michael Højby Rasmussen6; Rikke Beck Bang7; Reiko Horikawa8
ORAL PRESENTATION
Predicting weekly average IGF-I concentration for once-weekly somapacitan in children with growth hormone deficiency
Philippe F. Backeljauw1; Yassine Kamal Lyauk2; Joanne C. Blair3; Bradley S. Miller4; Jun Mori5; Michael Højby Rasmussen2; Rasmus Juul Kildemoes2
Keywords